February panel for Serono's Rebif

The FDA's Peripheral & Nervous System Drugs Advisory Committee will review on Feb. 15,

Read the full 143 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE